The authors observed that depletion of ARID1A or ARID1B results in an increased rate of cell proliferation in the sympathoadrenal lineage, which ultimately leads to higher tumor penetrance (Shi et al., 2020). The gene discussed is ARID1A; the disease is neoplasm.